Ophthalmic Business Council
For more than 20 years, the Foundation has facilitated the Ophthalmic Business Council (OBC) with the goal of fostering communication among leaders in the ophthalmic community. The OBC provides an ideal forum for thought leaders from the Academy, industry, government and health policy to collaborate face-to-face on ways to improve patient care.
OBC members are invited to attend two essential symposia with unparalleled networking opportunities with Academy physician leaders and industry experts.
To join or learn more, contact Todd Lyckberg at 415.447.0361 or firstname.lastname@example.org.
Download brochures: AAO 2017 exhibitors and non-exhibitors
Save the Date
Spring 2017 Symposium
Fall 2017 Symposium
Sept. 7 - 8
Held in conjunction with the Academy’s Board of Trustees meeting, the Fall Symposium covers the most timely and relevant issues facing ophthalmology today. In-depth presentations and open-forum discussions allow you to hear from all perspectives: physician, industry, health policy and government. The Fall Symposium is the perfect way to gain meaningful insights from key players.
Held every other year, the Spring Symposium focuses on the latest first-hand from experts on FDA, Medicare and reimbursement issues. As the speed of innovation grows, this event helps you navigate the complexities of introducing new technologies and treatments to patients. Unlike the Fall Symposium, Academy leaders do not attend this meeting.
2016 - 2017 Ophthalmic Business Council
Crown Benefactors ($25,000)
Regeneron Pharmaceuticals, Inc.
Abbott Medical Optics, Inc.
Bausch + Lomb
Janssen Global Services, LLC
Carl Zeiss Meditec, Inc.
Clearside Biomedical, Inc.
Notal Vision, Inc.
Aerie Pharmaceuticals, Inc.
Spark Therapeutics, Inc.
VISTAKON, Johnson & Johnson Vision Care, Inc.
Alimera Sciences, Inc.
New World Medical, Inc.
Topcon Medical Systems, Inc.